Finance

Lists
Why is ARTV down 2,62%?
Dive Deeper
ARTV:NASDAQ
Artiva Biotherapeutics Inc
6,12 $
-2,62%
(-0,16) 1D
14 հոկ, 11:46:32 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
6,21 $
High
6,25 $
Low
5,91 $
Mkt. cap
299,21 մլն
Avg. vol.
466,25 հզր
Volume
243,44 հզր
52-wk high
14,53 $
52-wk low
2,75 $
EPS
-3,31 $
Shares outstanding
48,89 մլն
No. of employees
115
Open
6,21 $
High
6,25 $
Low
5,91 $
Mkt. cap
299,21 մլն
Avg. vol.
466,25 հզր
Volume
243,44 հզր
52-wk high
14,53 $
52-wk low
2,75 $
EPS
-3,31 $
Shares outstanding
48,89 մլն
No. of employees
115
News stories
From web sources and news partners
About Artiva Biotherapeutics Inc
CEO-
Employees115
Founded2019
Headquarters-
Sector-
Websiteartivabio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ARTV in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current 6,12 $
41,00 $ (+569,39%)
Average
38,00 $ (+520,41%)
Lowest
35,00 $ (+471,43%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gil Blum
Needham
Buy
Maintained
41,00 $
+569,4%
10/01/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
35,00 $
+471,4%
10/01/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
40,00 $
+553,1%
05/25/2026
Unknown Analyst
Jefferies
Buy
Maintained
23,00 $
+275,5%
05/21/2026
Martin Fan
Wedbush
Buy
Maintained
40,00 $
+553,1%
05/21/2026
David Nierengarten
Wedbush
Buy
Maintained
40,00 $
+553,1%
05/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17,63 մլն
16,99 մլն
19,31 մլն
21,92 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,26 մլն
4,94 մլն
5,12 մլն
4,96 մլն
Operating expense
22,90 մլն
21,93 մլն
24,43 մլն
26,89 մլն
Total operating expenses
22,90 մլն
21,93 մլն
24,43 մլն
26,89 մլն
Operating income
-22,90 մլն
-21,93 մլն
-24,43 մլն
-26,89 մլն
Other non operating income
-3,00 հզր
-1,88 մլն
2,00 հզր
-1,00 հզր
EBT including unusual items
-21,53 մլն
-20,77 մլն
-23,52 մլն
-25,00 մլն
EBT excluding unusual items
-21,53 մլն
-22,65 մլն
-23,52 մլն
-25,00 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21,53 մլն
-20,77 մլն
-23,52 մլն
-25,00 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,88
-0,84
-0,95
-0,63
Interest and investment income
1,37 մլն
1,16 մլն
912,00 հզր
1,89 մլն
Interest expense
-
-
-
-
Net interest expenses
1,37 մլն
1,16 մլն
912,00 հզր
1,89 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-22,24 մլն
-21,27 մլն
-23,76 մլն
-26,20 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps